Schizophrenia Symptoms: Delusion of Control, Depersonalisation, and Delusions of Misidentification

Delusion of control, also known as passivity experience, is a primary symptom of schizophrenia identified by Schneider. This symptom is characterized by the belief that one’s body, mind, volition, or emotion is being controlled by another entity, being, or force. On the other hand, depersonalisation is the feeling of being disconnected from reality, often accompanied by derealisation.

Delusions of misidentification, another symptom of schizophrenia, can be divided into two types: Fregoli Syndrome and Capgras Syndrome. Fregoli Syndrome is the belief that someone whose appearance is unfamiliar is actually someone you know, while Capgras Syndrome is the belief that someone who looks familiar is an imposter.

Overall, these symptoms can significantly impact an individual’s perception of reality and their ability to function in daily life. It is important to seek professional help if experiencing any of these symptoms or suspecting someone else may be experiencing them.

Understanding Ego Defenses

Ego defenses are psychological mechanisms that individuals use to protect themselves from unpleasant emotions or thoughts. These defenses are classified into four levels, each with its own set of defense mechanisms. The first level, psychotic defenses, is considered pathological as it distorts reality to avoid dealing with it. The second level, immature defenses, includes projection, acting out, and projective identification. The third level, neurotic defenses, has short-term benefits but can lead to problems in the long run. These defenses include repression, rationalization, and regression. The fourth and most advanced level, mature defenses, includes altruism, sublimation, and humor.

Despite the usefulness of understanding ego defenses, their classification and definitions can be inconsistent and frustrating to learn for exams. It is important to note that these defenses are not necessarily good or bad, but rather a natural part of human behavior. By recognizing and understanding our own ego defenses, we can better manage our emotions and thoughts in a healthy way.

Types of Delusions

Grandiose delusions are a type of delusion where the individual has an inflated sense of self-importance. They believe that they are related to a higher figure, such as a deity, a monarch, or a celebrity. They may also believe that they possess great wealth, power, or social status. These delusions are commonly seen in individuals with bipolar disorder during manic episodes, as well as in other psychotic disorders.

On the other hand, erotomanic delusions are a type of delusion where the individual believes that someone of a higher social status is in love with them. This type of delusion can be dangerous, as the individual may become obsessed with the object of their delusion and may engage in stalking or other inappropriate behaviors.

Psychomotor Retardation in Severe Depression

Psychomotor retardation is a cognitive symptom commonly observed in individuals with severe depression. It is characterized by a significant slowing down of both thinking and behavior. This symptom can manifest in various ways, such as slowed speech, reduced movement, and delayed responses.

In contrast, other disorders such as mania and schizophrenia are associated with different forms of thought disorders. Mania is characterized by racing thoughts and impulsivity, while schizophrenia is associated with disorganized thinking and delusions.

It is important to recognize the presence of psychomotor retardation in individuals with severe depression as it can significantly impact their daily functioning and quality of life. Treatment options for this symptom may include medication, psychotherapy, and lifestyle changes. By addressing this symptom, individuals with severe depression can improve their overall well-being and ability to function in their daily lives.

Psychomotor Retardation in Depression

Psychomotor retardation is a common manifestation of depression, characterized by slow movement, speech, and rigidity in limbs. Patients may also exhibit a bent body posture and feelings of emptiness and hopelessness. It is crucial to rule out other potential causes, such as medication side effects or neurological disorders like Parkinson’s disease.

In severe cases, psychomotor retardation can progress to catatonia, where the patient is unresponsive to external stimuli despite being awake. It is essential to recognize and address these symptoms promptly to ensure proper diagnosis and treatment. By the signs and symptoms of psychomotor retardation, healthcare professionals can provide appropriate care and support to individuals experiencing depression.

Personality Disorders and their Characteristics

Janet’s behavior suggests that she may have emotionally unstable personality disorder – borderline type. This disorder is characterized by emotional instability, impulsivity, and deliberate attempts at self-harm. Individuals with this disorder often have intense but unstable relationships and feel a chronic sense of emptiness. Traumatic events in childhood may also be a factor.

In contrast, emotionally unstable personality disorder – impulsive type is characterized by explosive outbursts due to poor impulse control. These individuals may be quarrelsome and easily enter into conflict, particularly when their impulsive or explosive acts are interrupted.

Depressive episodes are characterized by low mood and other symptoms such as anhedonia, emotional blunting, changes in appetite and sleep patterns, feelings of guilt, and thoughts of suicide or death. Although Janet has taken an overdose, there are no other indications of a depressive episode in her history. However, a more detailed history may be necessary to determine if she is experiencing these symptoms or any other psychiatric illnesses.

It is important to note that individuals with personality disorders may also suffer from other psychiatric illnesses, known as co-morbidity. Histrionic personality disorder is characterized by shallow and labile affectivity, self-dramatization, theatricality, egocentricity, and a continual need for appreciation, excitement, and attention. Anakastic personality disorder is similar to obsessive-compulsive personality disorder and is characterized by preoccupation with detail, rules, organization, and schedules, which can hinder completion of tasks and relationships.

Overall, the characteristics of different personality disorders can help in identifying and treating individuals who may be struggling with these conditions.

Types of Hallucinations

Hypnogogic and hypnopompic hallucinations are two types of hallucinations that occur during the sleep cycle. Hypnogogic hallucinations happen when a person is falling asleep and can be auditory, visual, tactile, or kinaesthetic. On the other hand, hypnopompic hallucinations occur when a person is waking up, and the hallucination continues even after the person opens their eyes. These types of hallucinations are not indicative of any psychopathology and can occur in individuals with narcolepsy.

Reflex hallucinations are another type of hallucination that occurs when a true sensory stimulus causes an hallucination in another sensory modality. Autoscopy is a unique experience where an individual sees themselves and knows that it is themselves. This experience is visual and is sometimes referred to as the ‘phantom mirror image.’ Finally, auditory illusions occur when an auditory stimulus is misrepresented or misinterpreted by the listener.

In summary, there are various types of hallucinations that can occur in different stages of the sleep cycle or due to sensory stimuli. While these experiences may seem unusual, they do not necessarily indicate any underlying mental health issues.

Korsakoff’s syndrome is caused by untreated thiamine deficiency, which is also the underlying reason for Wernicke-korsakoff syndrome. Wernicke encephalopathy is an acute neurological deterioration due to thiamine deficiency, while Korsakoff’s syndrome is a chronic neurological deterioration characterized by deficits in memory and confabulation. In this case, the patient’s confabulation is likely due to retrograde memory impairment, which is a feature of Korsakoff’s syndrome. The patient’s history of alcoholism suggests a thiamine deficiency, which can lead to Wernicke-korsakoff syndrome. While alcohol withdrawal is a possible differential, it alone cannot explain the patient’s confabulation. It is important to exclude organic causes before assuming the patient is actively lying.

Understanding Korsakoff’s Syndrome

Korsakoff’s syndrome is a memory disorder that is commonly observed in individuals who have a history of alcoholism. This condition is caused by a deficiency in thiamine, which leads to damage and haemorrhage in the mammillary bodies of the hypothalamus and the medial thalamus. Korsakoff’s syndrome often follows untreated Wernicke’s encephalopathy, which is another condition caused by thiamine deficiency.

The primary features of Korsakoff’s syndrome include anterograde amnesia, which is the inability to acquire new memories, and retrograde amnesia. Individuals with this condition may also experience confabulation, which is the production of fabricated or distorted memories to fill gaps in their recollection.

Understanding Korsakoff’s syndrome is crucial for individuals who have a history of alcoholism or thiamine deficiency. Early diagnosis and treatment can help prevent further damage and improve the individual’s quality of life. Proper nutrition and abstinence from alcohol are essential for managing this condition.

PTSD is characterized by a set of common features, including re-experiencing, avoidance, and hyperarousal. Patients may experience intrusive flashbacks or nightmares related to the traumatic event. PTSD can develop after exposure to a variety of traumatic events, such as accidents, natural disasters, military exposure, and traumatic births. Healthcare workers during the COVID-19 pandemic have also reported experiencing PTSD. Insomnia is a common symptom associated with PTSD, while excessive sleep is not. Although hallucinations have been reported in some patients with PTSD, they are not as common as flashbacks and should prompt doctors to consider other possible diagnoses. Joint pains may occur in patients with PTSD, but they are not a defining feature of the disease.

Understanding Post-Traumatic Stress Disorder (PTSD)

Post-traumatic stress disorder (PTSD) is a mental health condition that can develop in individuals of any age following a traumatic event. This can include natural disasters, physical or sexual assault, or military combat. PTSD is characterized by a range of symptoms, including re-experiencing the traumatic event through flashbacks or nightmares, avoidance of triggers associated with the event, hyperarousal, emotional numbing, depression, and substance abuse.

Effective management of PTSD involves a range of interventions, including watchful waiting for mild symptoms, trauma-focused cognitive behavioral therapy (CBT), and eye movement desensitization and reprocessing (EMDR) therapy for more severe cases. While drug treatments are not recommended as a first-line treatment for adults, venlafaxine or a selective serotonin reuptake inhibitor (SSRI) such as sertraline may be used. In severe cases, risperidone may be recommended. It is important to note that single-session interventions, also known as debriefing, are not recommended following a traumatic event.

Understanding PTSD and its symptoms is crucial in providing effective support and treatment for those who have experienced trauma. With the right interventions, individuals with PTSD can learn to manage their symptoms and improve their quality of life.

Schizophrenia can be indicated by the presence of persecutory delusions, while the symptoms of depression align with the diagnosis. Guilty delusions, specifically, are a symptom commonly seen in cases of psychotic depression.

Screening and Assessment of Depression

Depression is a common mental health condition that affects many people worldwide. Screening and assessment are important steps in identifying and managing depression. The screening process involves asking two simple questions to determine if a person is experiencing symptoms of depression. If the answer is yes to either question, a more in-depth assessment is necessary.

Assessment tools such as the Hospital Anxiety and Depression (HAD) scale and the Patient Health Questionnaire (PHQ-9) are commonly used to assess the severity of depression. The HAD scale consists of 14 questions, seven for anxiety and seven for depression. Each item is scored from 0-3, producing a score out of 21 for both anxiety and depression. The PHQ-9 asks patients about nine different problems they may have experienced in the last two weeks, which can then be scored from 0-3. This tool also includes questions about thoughts of self-harm.

The DSM-IV criteria are used by NICE to grade depression. This criteria includes nine different symptoms, such as depressed mood, diminished interest or pleasure in activities, and feelings of worthlessness or guilt. The severity of depression can range from subthreshold depressive symptoms to severe depression with or without psychotic symptoms.

In conclusion, screening and assessment are crucial steps in identifying and managing depression. By using tools such as the HAD scale and PHQ-9, healthcare professionals can accurately assess the severity of depression and provide appropriate treatment.

A prodromal phase characterized by social withdrawal is linked to a negative prognosis in individuals with schizophrenia.

Schizophrenia is a mental disorder that can have varying outcomes for individuals. There are certain factors that have been associated with a poor prognosis, meaning a less favorable outcome. These factors include a strong family history of the disorder, a gradual onset of symptoms, a low IQ, a prodromal phase of social withdrawal, and a lack of an obvious precipitant for the onset of symptoms. It is important to note that these factors do not guarantee a poor outcome, but they may increase the likelihood of it. It is also important to seek treatment and support regardless of these factors, as early intervention and ongoing care can greatly improve outcomes for individuals with schizophrenia.

Clozapine, an antipsychotic medication used to treat refractory schizophrenia, requires continuous monitoring for patients taking it. This involves weekly blood tests for the first 18 weeks, followed by bi-weekly tests until the first year, and then monthly tests thereafter.

Atypical antipsychotics are now recommended as the first-line treatment for patients with schizophrenia, as per the 2005 NICE guidelines. These agents have a significant advantage over traditional antipsychotics in that they cause fewer extrapyramidal side-effects. However, atypical antipsychotics can still cause adverse effects such as weight gain, hyperprolactinaemia, and clozapine-associated agranulocytosis. Elderly patients who take antipsychotics are at an increased risk of stroke and venous thromboembolism, according to the Medicines and Healthcare products Regulatory Agency.

Clozapine is one of the first atypical antipsychotics to be developed, but it carries a significant risk of agranulocytosis. Therefore, full blood count monitoring is essential during treatment. Clozapine should only be used in patients who are resistant to other antipsychotic medication. The BNF recommends introducing clozapine if schizophrenia is not controlled despite the sequential use of two or more antipsychotic drugs, one of which should be a second-generation antipsychotic drug, each for at least 6-8 weeks. Clozapine can cause adverse effects such as reduced seizure threshold, constipation, myocarditis, and hypersalivation. Dose adjustment of clozapine may be necessary if smoking is started or stopped during treatment.

To ensure patient safety, it is important to monitor the full blood count for signs of agranulocytosis/neutropenia, a severe adverse reaction associated with clozapine.

Atypical antipsychotics are now recommended as the first-line treatment for patients with schizophrenia, as per the 2005 NICE guidelines. These agents have a significant advantage over traditional antipsychotics in that they cause fewer extrapyramidal side-effects. However, atypical antipsychotics can still cause adverse effects such as weight gain, hyperprolactinaemia, and clozapine-associated agranulocytosis. Elderly patients who take antipsychotics are at an increased risk of stroke and venous thromboembolism, according to the Medicines and Healthcare products Regulatory Agency.

Clozapine is one of the first atypical antipsychotics to be developed, but it carries a significant risk of agranulocytosis. Therefore, full blood count monitoring is essential during treatment. Clozapine should only be used in patients who are resistant to other antipsychotic medication. The BNF recommends introducing clozapine if schizophrenia is not controlled despite the sequential use of two or more antipsychotic drugs, one of which should be a second-generation antipsychotic drug, each for at least 6-8 weeks. Clozapine can cause adverse effects such as reduced seizure threshold, constipation, myocarditis, and hypersalivation. Dose adjustment of clozapine may be necessary if smoking is started or stopped during treatment.

Nihilistic Delusions and Cotard Syndrome

Nihilistic delusions are a severe form of negative thinking often experienced by depressed patients. These delusions are characterized by an exaggerated belief that all or part of the patient’s body, mind, or the world has ceased to exist. Patients may report that they do not have a brain or bowel, or that their body has died and they are awaiting a burial. This type of thinking is associated with a lack of insight and can be dangerous, particularly if the patient refuses to eat or drink. Urgent treatment, such as electroconvulsive therapy (ECT), may be necessary.

Nihilistic delusions are not limited to depression and can also occur in psychotic disorders like schizophrenia and organic disorders like delirium. Cotard syndrome is a specific type of nihilistic delusion where the patient believes that they are dead. This syndrome is often associated with depression and can be a sign of severe mental illness.

Splitting is a belief that individuals are either completely good or completely bad at different times, which stems from an inability to tolerate ambiguity. This behavior is frequently observed in individuals with borderline personality disorder. Other related behaviors include idealization, which involves expressing overly positive thoughts about oneself and others while disregarding negative thoughts, identification, which is the unconscious adoption of another person’s characteristics, qualities, or traits, and projection, which involves attributing an unacceptable internal impulse to an external source (as opposed to displacement).

Understanding Ego Defenses

Ego defenses are psychological mechanisms that individuals use to protect themselves from unpleasant emotions or thoughts. These defenses are classified into four levels, each with its own set of defense mechanisms. The first level, psychotic defenses, is considered pathological as it distorts reality to avoid dealing with it. The second level, immature defenses, includes projection, acting out, and projective identification. The third level, neurotic defenses, has short-term benefits but can lead to problems in the long run. These defenses include repression, rationalization, and regression. The fourth and most advanced level, mature defenses, includes altruism, sublimation, and humor.

Despite the usefulness of understanding ego defenses, their classification and definitions can be inconsistent and frustrating to learn for exams. It is important to note that these defenses are not necessarily good or bad, but rather a natural part of human behavior. By recognizing and understanding our own ego defenses, we can better manage our emotions and thoughts in a healthy way.

The young girl in question appears to be suffering from anorexia nervosa, as she is overly concerned with her weight despite having a low body mass index. It is common for females of a young age to develop this condition, and it is often accompanied by depression, which can manifest as low mood, loss of interest in hobbies, and sleep disturbances.

One recommended antidepressant for patients with anorexia nervosa is mirtazapine, as it can also increase appetite and promote weight gain. Fluoxetine, a selective serotonin reuptake inhibitor, is not contraindicated for anorexia nervosa, but it can cause gastrointestinal distress or sexual dysfunction, which may make it difficult for young patients to comply with the medication. Amitriptyline, a tricyclic antidepressant, is typically used for major depression but has a worse side-effect profile than selective serotonin reuptake inhibitors. Bupropion, an atypical antidepressant commonly used for smoking cessation, is not recommended for patients with anorexia nervosa or bulimia nervosa, as it can lower the seizure threshold and increase the risk of seizures.

Selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for depression, with citalopram and fluoxetine being the preferred options. They should be used with caution in children and adolescents, and patients should be monitored for increased anxiety and agitation. Gastrointestinal symptoms are the most common side-effect, and there is an increased risk of gastrointestinal bleeding. Citalopram and escitalopram are associated with dose-dependent QT interval prolongation and should not be used in certain patients. SSRIs have a higher propensity for drug interactions, and patients should be reviewed after 2 weeks of treatment. When stopping a SSRI, the dose should be gradually reduced over a 4 week period. Use of SSRIs during pregnancy should be weighed against the risks and benefits.

One of the most significant risk factors for future suicide completion is a history of previous suicide attempts, even when other risk factors such as male sex, young or elderly age, depression, alcohol or drug use, lack of social support, and expressed future intent are present.

The risk of suicide in psychiatric patients is often stratified into high, medium, or low risk categories, but there is limited evidence on the positive predictive value of individual risk factors. A review in the BMJ concluded that these assessments may not be useful in guiding decision making, as 50% of suicides occur in patients deemed low risk. However, certain factors have been associated with an increased risk of suicide, such as male sex, history of deliberate self-harm, alcohol or drug misuse, mental illness, depression, schizophrenia, chronic disease, advancing age, unemployment or social isolation, and being unmarried, divorced, or widowed.

If a patient has attempted suicide, there are additional factors that increase the risk of completed suicide in the future, such as efforts to avoid discovery, planning, leaving a written note, final acts such as sorting out finances, and using a violent method. On the other hand, there are protective factors that can reduce the risk of suicide, such as having family support, having children at home, and having a religious belief.

Zopiclone is a non-benzodiazepine used for insomnia and anxiety by stimulating the α-subunit of the GABA receptor. It should be used with caution due to addiction and tolerance. Benzodiazepines work through direct stimulation of GABA receptors, while promethazine and cyclizine are H1 receptor antagonists that cause sedation as a side effect.

Understanding Z Drugs

Z drugs are a class of medications that have comparable effects to benzodiazepines but differ in their chemical structure. They work by targeting the α2-subunit of the GABA receptor. Z drugs can be categorized into three groups: imidazopyridines, cyclopyrrolones, and pyrazolopyrimidines. Examples of these drugs include zolpidem, zopiclone, and zaleplon, respectively.

Like benzodiazepines, Z drugs can cause similar adverse effects. Additionally, they can increase the risk of falls in older adults. It is important to understand the potential risks and benefits of these medications before use and to follow the prescribed dosage and instructions carefully.

Understanding Ego Defenses

Ego defenses are psychological mechanisms that individuals use to protect themselves from unpleasant emotions or thoughts. These defenses are classified into four levels, each with its own set of defense mechanisms. The first level, psychotic defenses, is considered pathological as it distorts reality to avoid dealing with it. The second level, immature defenses, includes projection, acting out, and projective identification. The third level, neurotic defenses, has short-term benefits but can lead to problems in the long run. These defenses include repression, rationalization, and regression. The fourth and most advanced level, mature defenses, includes altruism, sublimation, and humor.

Despite the usefulness of understanding ego defenses, their classification and definitions can be inconsistent and frustrating to learn for exams. It is important to note that these defenses are not necessarily good or bad, but rather a natural part of human behavior. By recognizing and understanding our own ego defenses, we can better manage our emotions and thoughts in a healthy way.

Risperidone, an atypical antipsychotic, often causes hyperprolactinaemia as a side effect.

Atypical antipsychotics are now recommended as the first-line treatment for patients with schizophrenia, as per the 2005 NICE guidelines. These agents have a significant advantage over traditional antipsychotics in that they cause fewer extrapyramidal side-effects. However, atypical antipsychotics can still cause adverse effects such as weight gain, hyperprolactinaemia, and clozapine-associated agranulocytosis. Elderly patients who take antipsychotics are at an increased risk of stroke and venous thromboembolism, according to the Medicines and Healthcare products Regulatory Agency.

Clozapine is one of the first atypical antipsychotics to be developed, but it carries a significant risk of agranulocytosis. Therefore, full blood count monitoring is essential during treatment. Clozapine should only be used in patients who are resistant to other antipsychotic medication. The BNF recommends introducing clozapine if schizophrenia is not controlled despite the sequential use of two or more antipsychotic drugs, one of which should be a second-generation antipsychotic drug, each for at least 6-8 weeks. Clozapine can cause adverse effects such as reduced seizure threshold, constipation, myocarditis, and hypersalivation. Dose adjustment of clozapine may be necessary if smoking is started or stopped during treatment.

Types of Hallucinations and Illusions

Functional hallucinations are auditory hallucinations that occur in response to an external stimulus. The individual can distinguish between the stimulus and the hallucination, and the hallucination only occurs when the stimulus is present. Reflex hallucinations, on the other hand, occur when a sensory stimulus in one modality causes a hallucination in another modality.

Autoscopy, also known as phantom mirror-image, is the experience of seeing oneself and recognizing that it is oneself. This can be a disorienting experience, as the individual may feel as though they are outside of their own body. Extracampine hallucinations occur when an individual experiences a hallucination outside of their own sensory field, such as seeing something behind them when they are looking straight ahead.

Auditory illusions occur when an auditory stimulus is misinterpreted by the listener. This can happen when the listener is in a noisy environment or when the sound is distorted in some way. It is important to note that hallucinations and illusions can be symptoms of various mental health conditions and should be evaluated by a medical professional.

Wernicke’s Encephalopathy

Wernicke’s encephalopathy is a condition that is linked to bleeding in the mamillary bodies of the brain. This condition is commonly seen in patients who have a deficiency in thiamine. The symptoms of Wernicke’s encephalopathy include an altered mental state, difficulty with coordination and balance, and ophthalmoplegia. This condition is particularly problematic for individuals who abuse alcohol as they often rely on alcohol for their daily caloric intake.

Wernicke’s encephalopathy is a serious condition that can have long-lasting effects on a person’s health. With proper treatment and care, it is possible to manage the symptoms of Wernicke’s encephalopathy and improve overall health and well-being.

Understanding Obsessive-Compulsive Disorder

Obsessive-compulsive disorder (OCD) is a mental health condition that affects 1 to 2% of the population. It is characterized by the presence of obsessions, which are unwanted intrusive thoughts, images, or urges, and compulsions, which are repetitive behaviors or mental acts that a person feels driven to perform. OCD can cause significant functional impairment and distress.

The causes of OCD are multifactorial, with possible factors including genetics, psychological trauma, and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS). OCD is also associated with other mental health conditions such as depression, schizophrenia, Sydenham’s chorea, Tourette’s syndrome, and anorexia nervosa.

Treatment for OCD depends on the level of functional impairment. For mild impairment, low-intensity psychological treatments such as cognitive behavioral therapy (CBT) including exposure and response prevention (ERP) may be sufficient. If this is not effective or the patient cannot engage in psychological therapy, a course of an SSRI or more intensive CBT (including ERP) may be offered. For moderate impairment, a choice of either an SSRI or more intensive CBT (including ERP) may be offered. For severe impairment, combined treatment with an SSRI and CBT (including ERP) may be necessary.

ERP is a psychological method that involves exposing a patient to an anxiety-provoking situation and then stopping them from engaging in their usual safety behavior. This helps them confront their anxiety, and the habituation leads to the eventual extinction of the response. If treatment with an SSRI is effective, it should be continued for at least 12 months to prevent relapse and allow time for improvement. If an SSRI is ineffective or not tolerated, another SSRI may be tried.

Benzodiazepines are a class of drugs that act as central nervous system depressants by enhancing the effects of the neurotransmitter gamma-aminobutyric acid (GABA). They are commonly used to treat anxiety, insomnia, and seizures.

In March 2018, NICE released new guidelines for the recognition and management of Attention Deficit Hyperactivity Disorder (ADHD). This condition can have a significant impact on a child’s life and can continue into adulthood, making accurate diagnosis and treatment crucial. ADHD is defined by DSM-V as a persistent condition that includes features of inattention and/or hyperactivity/impulsivity, with an element of developmental delay. The threshold for diagnosis is six features for children up to 16 years old and five features for those aged 17 or over. ADHD has a prevalence of 2.4% in the UK, with a possible genetic component and a higher incidence in boys than girls.

NICE recommends a holistic approach to treating ADHD that is not solely reliant on medication. After presentation, a ten-week observation period should follow to determine if symptoms change or resolve. If symptoms persist, referral to secondary care is necessary, usually to a paediatrician with a special interest in behavioural disorders or to the local Child and Adolescent Mental Health Service (CAMHS). A tailored plan of action should be developed, taking into account the patient’s needs and wants and how their condition affects their lives.

Drug therapy should be considered a last resort and is only available to those aged 5 years or older. For patients with mild/moderate symptoms, parents attending education and training programmes can be beneficial. For those who fail to respond or have severe symptoms, pharmacotherapy can be considered. Methylphenidate is the first-line treatment for children and should be given on a six-week trial basis. Lisdexamfetamine can be used if there is an inadequate response, and dexamfetamine can be started in those who have benefited from lisdexamfetamine but cannot tolerate its side effects. In adults, methylphenidate or lisdexamfetamine are first-line options, with switching between drugs if no benefit is seen after a trial of the other.

All of these drugs have the potential to be cardiotoxic, so a baseline ECG should be performed before starting treatment. Referral to a cardiologist is necessary if there is any significant past medical history or family history, or any doubt or ambiguity. A thorough history and clinical examination are essential for accurate diagnosis, given the overlap of ADHD with many other psychiatric and physical conditions.

Obsessions and Phobic Thoughts

Obsessions are persistent and uncontrollable thoughts, images, impulses, or memories that cause significant distress to the individual. These thoughts are often irrational and excessive, but the person experiencing them is aware that they are their own. Unlike delusions, individuals with obsessions have insight into the irrationality of their thoughts. On the other hand, phobic thoughts are associated with avoidance, while obsessional thoughts are associated with compulsions. For instance, an individual with a fear of contamination may feel the need to repeatedly wash their hands to alleviate their anxiety.

In summary, obsessions and phobic thoughts are two different types of distressing mental experiences. While phobic thoughts are associated with avoidance, obsessional thoughts are associated with compulsions. It is important to seek professional help if these thoughts are interfering with daily life and causing significant distress.

Brief psychotic disorder is a condition characterized by a sudden onset of psychotic symptoms, such as hallucinations or delusions, that typically occurs in response to a stressful event. Individuals with a pre-existing personality disorder may be more susceptible to this condition. However, the good news is that brief psychotic disorder often resolves within a month, and patients typically return to their normal level of functioning. This disorder is most commonly seen in individuals in their 20s, 30s, and 40s, and patients may not always be aware of the changes in their behavior.

Understanding Psychosis: Symptoms and Associated Features

Psychosis is a term used to describe a person’s experience of perceiving things differently from those around them. This can manifest in a variety of ways, including hallucinations, delusions, thought disorganization, alogia, tangentiality, clanging, and word salad. These symptoms can be associated with agitation, aggression, neurocognitive impairment, depression, and thoughts of self-harm.

Psychotic symptoms can occur in a number of conditions, including schizophrenia, depression, bipolar disorder, puerperal psychosis, brief psychotic disorder, neurological conditions like Parkinson’s disease and Huntington’s disease, and as a result of prescribed drugs or certain illicit drugs like cannabis and phencyclidine.

The peak age of first-episode psychosis is around 15-30 years. It is important to understand the symptoms and associated features of psychosis in order to recognize and seek appropriate treatment for those experiencing these symptoms.

Respiratory depression is a known adverse effect of benzodiazepines, particularly when used in conjunction with other respiratory depressants like opioids. Symptoms of benzodiazepine withdrawal syndrome typically include tremors, anxiety, sweating, and seizures, but these are not considered adverse effects of benzodiazepine use.

Benzodiazepines are drugs that enhance the effect of the neurotransmitter GABA, which has an inhibitory effect on the brain. This makes them useful for a variety of purposes, including sedation, anxiety relief, muscle relaxation, and as anticonvulsants. However, patients can develop a tolerance and dependence on these drugs, so they should only be prescribed for short periods of time. When withdrawing from benzodiazepines, it is important to do so gradually, reducing the dose every few weeks. If patients withdraw too quickly, they may experience benzodiazepine withdrawal syndrome, which can cause a range of symptoms including insomnia, anxiety, and seizures. Other drugs, such as barbiturates, work in a similar way but have different effects on the duration or frequency of chloride channel opening.

Metabolic alkalosis, hypokalemia, and hypochloremia are commonly observed in individuals with bulimia nervosa, even if their BMI falls within a normal range. This is due to the excessive self-induced vomiting, which results in the loss of stomach acid (HCl) and potassium.

Understanding Bulimia Nervosa

Bulimia nervosa is an eating disorder that is characterized by recurrent episodes of binge eating followed by purging behaviors such as self-induced vomiting, misuse of laxatives, diuretics, or other medications, fasting, or excessive exercise. According to the DSM 5 diagnostic criteria, individuals with bulimia nervosa experience a sense of lack of control over eating during the episode, and the binge eating and compensatory behaviors occur at least once a week for three months. Recurrent vomiting may lead to erosion of teeth and Russell’s sign – calluses on the knuckles or back of the hand due to repeated self-induced vomiting.

Individuals with bulimia nervosa are unduly influenced by body shape and weight, and their self-evaluation is often based on these factors. It is important to note that the disturbance does not occur exclusively during episodes of anorexia nervosa. Referral for specialist care is appropriate in all cases, and NICE recommends bulimia-nervosa-focused guided self-help for adults. If this approach is not effective, individual eating-disorder-focused cognitive behavioral therapy (CBT-ED) may be considered. Children should be offered bulimia-nervosa-focused family therapy (FT-BN). While pharmacological treatments have a limited role, a trial of high-dose fluoxetine is currently licensed for bulimia, but long-term data is lacking.

In summary, bulimia nervosa is a serious eating disorder that requires specialized care. Early intervention and treatment can help individuals recover and improve their quality of life.

Types of Delusional Symptoms in Psychotic Disorders

Delusional perception is a symptom commonly seen in schizophrenia and other psychotic disorders. It occurs when a normal perception takes on a unique and delusional significance for the patient. For example, a red traffic light may be perceived as a sign of the end of the world. This symptom is considered a first rank symptom by psychiatrist Kurt Schneider.

Autochthonous delusions, also known as delusional intuitions, are sudden and unexplained delusions that arise in the patient’s mind. These delusions are not based on any external stimuli or perceptions, but rather grow from within the patient’s mind.

Delusional memories are memories that are partially based on true events from the past, but with delusional beliefs attached to them. For example, a patient may believe that a chip has been inserted in their head following a surgery to remove a cyst, even though this is not true.

Delusional atmosphere is a poorly understood phenomenon where the patient experiences an overwhelming feeling that something important is happening or that the world has changed, but they are unable to understand what or how. This feeling may be associated with anxiety, depression, or excitement, and can lead to the development of delusions.

In summary, delusional symptoms can take on various forms in psychotic disorders, including delusional perception, autochthonous delusions, delusional memories, and delusional atmosphere. These symptoms can greatly impact the patient’s perception of reality and require careful management and treatment.

Due to the increased risk of central serotonin syndrome, fluoxetine should not be prescribed alongside phenelzine, a non-selective and irreversible monoamine oxidase inhibitor (MAOI).

As the patient is not experiencing nausea or vomiting, there is no need to prescribe metoclopramide. Additionally, metoclopramide is not suitable for this patient with Parkinson’s disease as it can worsen their symptoms as a dopamine antagonist.

The patient’s senna should not be discontinued as it is likely necessary for regular bowel movements due to their history of diverticulosis. Lactulose may also be needed for this purpose.

As the patient is not reporting any pain, there is no need to increase their pain relief at this time.

Selective serotonin reuptake inhibitors (SSRIs) are the first-line treatment for depression, with citalopram and fluoxetine being the preferred options. They should be used with caution in children and adolescents, and patients should be monitored for increased anxiety and agitation. Gastrointestinal symptoms are the most common side-effect, and there is an increased risk of gastrointestinal bleeding. Citalopram and escitalopram are associated with dose-dependent QT interval prolongation and should not be used in certain patients. SSRIs have a higher propensity for drug interactions, and patients should be reviewed after 2 weeks of treatment. When stopping a SSRI, the dose should be gradually reduced over a 4 week period. Use of SSRIs during pregnancy should be weighed against the risks and benefits.